Mass Eye And Ear performs first FDA-approved gene therapy procedure for inherited disease

March 23, 2018
Read article how Mass Eye and Ear performs first FDA-approved gene therapy procedure for inherited disease: http://bit.ly/2pAiyus Dr. Katherine High, President and Chief Scientific Officer, will speak about Luxturna treatment at the Bertarelil Symposium on April 11. To register, visit https://bertarelli.hms.harvard.edu/symposium